Protection of GAP-43 gene–modified bone marrow mesenchymal stem cells on retinitis pigmentosa

The results suggest that GAP-43 gene modified BMSCs has the therapeutic effect on the early stage of retinal degeneration, which might make more photoreceptors preserved.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2026-01-09
DOI
https://doi.org/10.1186/s12967-026-07685-2
Primary Topic
Retinal Development and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protection of GAP-43 gene–modified bone marrow mesenchymal stem cells on retinitis pigmentosa

Yuxi He, Yuxiao Guo, Guanfang Su
Journal of Translational Medicine
Retinal Development and Disorders
article

Protection of GAP-43 gene–modified bone marrow mesenchymal stem cells on retinitis pigmentosa

Yuxi He, Yuxiao Guo, Guanfang Su
article en

Abstract

The results suggest that GAP-43 gene modified BMSCs has the therapeutic effect on the early stage of retinal degeneration, which might make more photoreceptors preserved.

Journal of Translational MedicineVol. 24(1)
Jilin Medical University (CN), Second Affiliated Hospital of Jilin University (CN)
Zero hunger
Openalex Percentile: Top 93%
Retinal Development and Disorders
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Protection of GAP-43 gene–modified bone marrow mesenchymal stem cells on retinitis pigmentosa — Yuxi He, Yuxiao Guo, et al. · Journal of Translational Medicine (2026) | TGRS Research Map | TGRS